Thursday, June 27, 2019

Glenmark Pharma gets USFDA nod for cholesterol lowering drug

Glenmark Pharma gets USFDA nod for cholesterol lowering drug The approval has been granted by the the United States Food and Drug Administration (USFDA) for for Ezetimibe and Simvastatin tablets in the strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, the company said in a statement.

from Moneycontrol Business News https://ift.tt/2LxxzZV

No comments:

Post a Comment

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...